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Summary 
In this study we investigated whether furanones could prevent biofilms from being formed. 
Our first aim was to find a new synthesis pathway for (Z)-5-bromomethylene-2(5H)-furanone, 
a furanone also produced in nature by the macro-alga Delisa pulchra, and to investigate its 
effects on biofilm formation by Streptococcus anginosus, Streptococcus intermedius, 
Streptococcus mutans and Staphylococcus epidermidis. We also synthesised 5-
(bromomethylene)furan-2(5H)-ones and 3-(bromomethylene)isobenzofuran-1(3H)-ones to 
further investigate their effects on biofilm formation by S. epidermidis. The effect on biofilm 
formation was assessed either by adding furanone to the growth medium or by allowing 
biofilm to form on surface-adsorbed furanone. Furanone effectively decreased biofilm 
formation by both application methods, but with surface-adsorbed furanone being most 
effective. The furanone concentrations used had no effect on microbial growth, and were also 
well below the established MICs, indicating that the effect was not a result of an antimicrobial 
effect. In order to determine whether the inhibitory effect was associated with the ability of 
furanone to interfere with microbial AI-2 communication, AI-2 deficient mutants were 
included.  In contrast to their wild types, the amount of biofilm formed by the communication 
defective S. anginosus and S. intermedius was not affected when adding furanone to the 
growth medium. Biofilm formation on surface-adsorbed furanone was unaffected or partially 
affected for the communication defective S. anginosus and S. intermedius mutants 
respectively. Adding DPD, the synthetic AI-2 communication signal, to the growth medium 
abolished the inhibitory effect of furanone on biofilm formation. Furthermore furanones were 
found to decrease bioluminescence by the AI-2 reporter strain. Taken together, these findings 
support the assumption that furanones interfere with microbial communication, without 
affecting microbial growth.  
Finally, we studied possible irritative and genotoxic effects of the furanones. Only 
after using 1000 times higher concentrations than used in the biofilm assay, did we see an 
irritative effect. There were no significant alterations of the genotoxic and global gene 
expression in mice treated with furanone.  
Interference with microbial communication thus may represent a novel and promising 
strategy to control biofilm related infections. 
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Sammandrag 
I denna studien har vi undersökt om furanoner kan förhindra bildandet av biofilmer. Vår 
första målsättning var att finna en ny syntesväg för (Z)-5-bromomethylene-2(5H)-furanone, en 
furanon som produceras naturligt av makro-algen Delisa pulchra, samt att undersöka dess 
effekt på biofilmer av Streptococcus anginosus, Streptococcus intermedius och Streptococcus 
mutans. Vi syntetiserade även 5-(bromomethylene)furan-2(5H)-ones och 3-
(bromomethylene)isobenzofuran-1(3H)-ones för att vidare kunna undersöka deras effekt på  
biofilm av Staphylococcus epidermidis. Effekten på biofilm blev undersökt genom att tillsätta 
furanoner till växtmediet eller genom att observera hur biofilm bildas på en ytadsorberad 
furanon. Furanonerna minskade effektivt bildandet av biofilm i båda applikationsmetoderna, 
men ytadsorberad furanon var mest effektiv. Koncentrationerna av furanon som användes 
hade ingen effekt på bakteriell tillväxt och koncentrationerna låg också långt under de 
fastställda MIC (Minimal Inhibitory Concentration)-värdena, vilket indikerade att effekten 
inte var ett resultat av en antimikrobiell effekt. För att kunna bestämma om den inhibitoriska 
effekten var associerad med furanonernas förmåga att påverka mikrobiell AI-2 
kommunikation, inkluderades en mutant som saknar förmåga att kommunicera genom AI-2. 
Till skillnad från motsvarande vildtyp var mängden biofilm bildad av S. anginosus and S. 
intermedius mutanterna, som saknar förmåga att kommunicera genom AI-2, inte påverkad av 
furanoner tillsatta till växtmediet. Mängd bildad biofilm av S. anginosus and S. intermedius 
mutanterna på ytadsorberad furanon var oförändrad eller endast delvis påverkad hos de 
respektive mutanterna. Genom att tillsätta DPD, den syntetiska AI-2 kommunikationssignalen, 
till växtmediet kunde den inhibitoriska effekten av furanon upphävas. Vidare fann vi att 
furanon minskade bioluminescence hos AI-2 reporter-stammen. Tillsammans understöder 
resultaten antagandet att furanoner påverkar mikrobiell kommunikation utan att påverka 
mikrobiell tillväxt. 
 Slutligen undersökte vi möjliga skadliga och genotoxiska effekter av furanoner. Först 
efter att ha använt 1000 gånger högre koncentrationer än de vi använde i biofilm-försöken såg 
vi en skadlig effekt. Vi såg inga signifikanta förändringar i våra genotoxiska tester hos möss 
som blivit behandlade med furanon. 
 Möjligheten att kunna påverka bakteriell kommunikation kan därför representera en ny 
och lovande strategi för att kunna kontrollera bakteriella biofilmrelaterade infektioner. 
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MIC      Minimum inhibitory concentration  
TFA      Trifluoroacetic acid  
F101     (Z)-5-(Bromomethylene)dihydrofuran-(3H)-one 
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F205     (E)-5-(Bromomethylene)-3,4-dimethylfuran-2(5H)-one 
F206     (Z)-3-Bromo-5-(bromomethylene)furan-2(5H)-one 
F207     (E)-5-(Bromomethylene)-3-phenylfuran-2(5H)-one 
F208     (Z)-5-(Bromomethylene)-3-phenylfuran-2(5H)-one 
F301     (E)-3-(Bromomethylene)isobenzofuran-1(3H)-one 
F302     (Z)-3-(Bromomethylene)isobenzofuran-1(3H)-one 
 8 
Introduction 
Biofilm and biofilm formation 
Microorganisms were long thought of as floating single cells, without the ability to interact 
with or react to their environment or surrounding microorganisms. During the last two 
decades, it has become clear that the preferred growth mode of microorganisms is in biofilms. 
Microorganisms in biofilms live in well-organised communities consisting of single or 
multiple species embedded in an organic polymer matrix adhering to a surface (Costerton et 
al., 1995). The first description of microbial biofilms was made as early as in the 1930s 
(ZoBell and Allen, 1933; ZoBell and Allen, 1935). Later microbial biofilms were found to be 
ubiquitous, as they were found in vastly different aquatic ecosystems in nature, in industry, 
and in medicine (Costerton et al., 1978; Costerton et al., 1995). The biofilm provides 
improved survival ability for the microorganisms through attachment to surfaces, as well as 
genetic heterogeneity. This may be seen as a specialisation of function, resembling the 
division of function seen in multicellular organisms (Jefferson, 2004). 
The process of biofilm formation is thought to be well regulated (Lazazzera, 2005). 
The process starts with the adhesion of planktonic microorganisms to a surface, followed by 
colonisation and co-adhesion, growth and maturation, and finally detachment of some 
microorganisms (Scheie and Petersen, 2004). At the first stage, the microorganisms are 
reversibly attached, and not yet committed to the biofilm differentiation process. To develop a 
mature biofilm, the adhesion must be irreversible and the microorganisms must grow in 
population. There are three mechanisms that may lead to colonisation and co-adhesion; 
redistribution of attached cells by surface motility, division of attached cells, or recruitment of 
planktonic cells to the developing biofilm. The biofilm formation is a dynamic process, thus 
attachment, co-adhesion and growth may occur at overlapping times. Which mechanism will 
be the most predominant depends on the organism involved, the nature of the surface being 
colonised, and the physical and chemical conditions of the environment. The maturation of 
the biofilm results in a complex architecture with channels and pores. The microorganisms, 
individually or in groups, may also be released from the biofilm surface to find other 
colonisation sites. It has been hypothesised that the released microorganisms have more 
similarity to planktonic microorganisms than to biofilm microorganisms, thereby closing the 
biofilm lifecycle (Stoodley et al., 2002).  
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Biofilms associated with infectious diseases 
All body fluids provide organic nutrients for microbial growth, and body surfaces may 
harbour various combinations of microorganisms, living in an ecological equilibrium with the 
host. In a commensal ecosystem within the body, inhabiting microorganisms may be a 
protection to the host. In case the balance shift to the advantage of specific microorganisms, 
diseases or infections may develop. There is a direct and dynamic relationship between an 
environment and its microflora, even at the microhabitat scale. Substantial changes to a 
habitat may cause an imbalance between the resident organisms (Costerton et al., 1995; 
Marsh, 2003). 
Within the microbial ecosystem of the oral cavity, we find a number of distinct 
surfaces with different key ecological factors. These factors enable some organisms to 
dominate at one site, whilst others dominate at others. Such distinct habitats include lips, 
cheek, palate, tongue, and teeth. Disruption of the balance at these sites may lead to dental 
caries or periodontal disease (Marsh, 2003). 
The oral cavity is an ecosystem easily accessible for research, making it a suitable 
model for biofilm studies. Several in vitro models mimicking this oral ecosystem have been 
applied. Results from these models have revealed the interactions and activity of 
microorganisms in the oral cavity, as well as contributed to the understanding of biofilms in 
general (Kolenbrander et al., 2002). Depending on the microbial composition, biofilm 
formation may be conducive with health, or lead to disease (Marsh, 2003). Biofilm formation 
may be critical for the pathogenesis (Costerton et al., 1999). 
Oral streptococci are commensals of the oral cavity and upper respiratory tract of 
humans and animals (Whiley and Beighton, 1998). They are primary colonisers, and as such 
mediate subsequent attachment of other microorganisms to form a mature oral biofilm (Nyvad 
and Kilian, 1987). Although they are commensals, oral streptococci are among the species 
that may be isolated from biofilm-infected medical devices (Donlan, 2001). Oral streptococci 
also account for half of all the cases of infective endocarditis (Costerton et al., 1999). 
The anginosus group, including Streptococcus anginosus, Streptococcus intermedius, 
and Streptococcus constellatus, are commensally present in saliva and gingival plaque 
(Whiley and Beighton, 1991; Whiley et al., 1993; Claridge et al., 2001) as well as in the 
gastrointestinal and the genito-urinal tracts (Piscitelli et al., 1992; Whiley et al., 1992). 
Members of the anginosus group have also been associated with infectious diseases. Both S. 
anginosus and S. intermedius are commonly isolated from endodontic infections in the root 
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canals (Gomes et al., 2004; Chavez de Paz et al., 2005), whilst S. intermedius has been 
isolated from periodontal disease (Haffajee et al., 1988), and implantitis (Tanner et al., 1997). 
Members of the anginosus group have also been found to colonise dental implant surfaces and 
may be the cause of early implant failure (Laine et al., 2005). The anginosus group may also 
be associated with septicaemia, as well as abscesses in for instance gastrointestinal and 
genito-urinal tracts, and the central nervous system (Whiley et al., 1992; Clarridge et al., 1999; 
Claridge et al., 2001). 
Streptococcus mutans is also a commensal of the oral flora. Preferentially, S. mutans 
colonises the tooth surface, and has also been found to colonise prosthetic devices. Their 
ability to adhere to smooth surfaces, as well as their acidogenic properties, are virulence 
factors associated with dental caries development.  Glucan-producing streptococci, including 
S. mutans, has also been connected with sub-acute endocarditis (Hamada and Slade, 1980). 
Staphylococcus epidermidis makes up a major part of the normal flora of human skin 
and was long considered to be a harmless commensal. However, in the past decades, S. 
epidermidis has emerged as a major pathogen in biofilm infections associated with medical 
devices (Hussain et al., 1993). The first observation of staphylococcal colonisation of medical 
devices was made in 1961 and was referred to as slime production. This slime production was 
thought of as a special feature for this particular strain (Callaghan et al., 1961). First in 1982, 
Christensen and co-workers realised that slime production could be an overlooked pathogenic 
characteristic of many S. epidermidis strains (Christensen et al., 1982). 
The increased use of implanted medical devices, as well as the increased use of 
antimicrobials, have turned S. epidermidis to one of the major causes of nosomical infections. 
Today, infections by S. epidermidis are associated with a broad spectrum of medical devices, 
such as vascular catheters (Raad and Bodey, 1992; Rupp and Archer, 1994), cerebrospinal 
shunts (van Ek et al., 1986), and prosthetic joints (Inman et al., 1984). The increasing use of 
antimicrobials to prevent and treat infections in hospitalised patients have led to the 
emergence of multi resistant S. epidermidis (Raad et al., 1998). 
Microbial communication 
Microorganisms respond to their fellow habitants and sense the surrounding environmental 
conditions through different mechanisms. One way to achieve this is through a process where 
the microorganisms react to signalling molecules by altering their gene expression in a density 
dependent manner, so called quorum sensing. 
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Cell-cell communication was described already in the 1960s. Pakula and Walczak 
described an exocellular factor that provoked competence in streptococci under certain 
conditions and upon addition to non-competent cultures (Pakula and Walczak, 1963). In 1964, 
Kerravala and co-workers demonstrated that Bacillus subtilis and Bacillus cereus strains 
produced an endogenous factor that initiated sporogenesis in vegetative cells not yet 
committed to sporulation. The initiation of sporogenesis occurred at specific cell densities 
(Kerravala et al., 1964). Shortly after, data indicated that the competent state in 
“Pneumococcus” (later Streptococcus pneumoniae), was regulated by an extracellular 
activator. This behaviour was described as an environmental sensing mechanism which was 
termed autoinduction (Tomasz, 1965). Later, studies of the marine light producing 
microorganism Vibrio fischeri revealed that light emission was induced by a signalling 
molecule, termed autoinducer (AI). As this AI accumulated, the microorganisms responded 
by synthesizing luminescence enzymes (Nealson et al., 1970; Nealson, 1977). In the 1980s, a 
model for autoinduction in V. fischeri was suggested.  This model indicated that the 
transcription of different genes was controlled by a threshold AI concentration. The AIs were 
suggested to be produced intracellularly, diffusing to the outside, and thereby being able to 
signal to neighbouring microorganisms (Engebrecht et al., 1983; Kaplan and Greenberg, 
1985). Quorum sensing allows microorganisms to regulate genes according to cell density, 
thereby inducing a behavioural response throughout the whole population. Genes controlled 
by quorum sensing are connected to behaviour being productive only when carried out by 
many microorganisms simultaneously, e.g. secretion of virulence factors, biofilm formation, 
sporulation and bioluminescence (Miller and Bassler, 2001; Henke and Bassler, 2004). 
The three most studied quorum sensing communication systems involve the LuxI/R 
system using acylated homoserine lactones (AHLs) as autoinducers for species specific 
communication in Gram negative microorganisms, the oligopeptide autoinducer system for 
species specific communication in Gram positive microorganisms, and an interspecies system 
used by both Gram negative and Gram positive microorganisms using a furanosyl borate di-
ester termed autoinducer-2 (AI-2) as the signalling molecule (Henke and Bassler, 2004). 
Autoinducer-2 
The communication based on AI-2 was first described in Vibrio harveyi (Bassler et al., 1994), 
and was later suggested to be a common intra- and inter-species communication system 
(Bassler et al., 1997). AI-2 is a product of the LuxS enzyme (Schauder et al., 2001; Xavier 
and Bassler, 2003), and a by-product of the metabolic activated methyl cycle that recycles S-
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adenosylmethionine (Sun et al., 2004). The LuxS coding gene is conserved in a majority of 
sequenced Gram-positive and Gram-negative microbial genomes (Chung et al., 2001; Fong et 
al., 2001; Frias et al., 2001; Burgess et al., 2002; Wen and Burne, 2002; McNab et al., 2003; 
Merritt et al., 2003; Vendeville et al., 2005; Yoshida et al., 2005; Petersen et al., 2006), 
suggesting that AI-2 may function as a universal language for interspecies communication 
(Vendeville et al., 2005).  
Supernatants from oral streptococci, including S. anginosus, S. intermedius, and S. 
mutans, induced bioluminescence in the V. harveyi BB170 reporter sensing AI-2. This 
suggests that these streptococci produce an AI-2 like molecule for inter-species 
communication (Petersen et al., 2006). LuxS is identified in various oral microorganisms, 
including S. anginosus, S. intermedius, and S. mutans, where AI-2 has been associated with 
virulence and biofilm formation (Merritt et al., 2003; Wen and Burne, 2004; Yoshida et al., 
2005; Petersen et al., 2006; Ahmed et al., 2008). 
 LuxS has also been identified in S. epidermidis, suggesting that AI-2 has a signalling 
function in S. epidermidis (Xu et al., 2006). However, the mechanism of AI-2, and data on the 
role in biofilm formation are inconclusive (Kong et al., 2006). 
Prevention and treatment of implant related biofilm infections 
There is a close relationship between biofilms and infectious diseases, both for conditions 
such as cystic fibrosis and periodontitis, as well as infections in the bloodstream and urinary 
tract resulting from various indwelling medical devices (Donlan and Costerton, 2002). 
Plastic and metallic surfaces of medical implants may accrete microorganisms 
dislodged from the body surfaces, thus leading to infection. Shear forces, such as blood flow 
or blinking of the eye when wearing contact lenses, is not sufficient to prevent microbial 
adhesion or biofilm formation. Once a biofilm is established on a medical device, the 
microorganisms are protected from host defence and antimicrobials (Costerton et al., 1995). 
Biofilms may be up to 1000-fold more resistant than their planktonic counterparts (Gilbert et 
al., 1997). Infections associated with biofilms on medical devices are extremely difficult to 
treat. This may be connected with restricted penetration of antimicrobials, decreased growth 
rate of biofilm cells, the expression of resistance genes, or the presence of persister cells 
(Costerton et al., 1999). 
Current approaches to control biofilm related implant infections concentrate on 
preventing initial device contamination and microbial attachment to the device, while 
treatment of an existing infection normally involves antimicrobial treatment and removal of 
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the device. Such approaches are, however not always effective in controlling biofilm 
infections and the risk of implant related microbial infections is still rather high (O'Gara and 
Humphreys, 2001; Donlan and Costerton, 2002). 
 A major concern is the development and spread of antimicrobial resistance. Infections 
once being easy to cure with antimicrobials are now becoming difficult, and sometimes even 
impossible, to treat due to multidrug resistance. In 2004, nearly 2 million people in the United 
States were assumed to acquire hospital associated microbial infections. More than 70 % of 
the microorganisms involved in these infections were thought to be resistant to at least one of 
the drugs used to fight them. Some of the resistant microorganisms, earlier found only in 
hospitals, are now found in the community, in otherwise healthy individuals. This gives an 
even greater risk of spreading resistant strains (Infectious Diseases Society of America, July, 
2004). 
Since few effective means to prevent medical device-related infections are currently 
available, research is called for. The antimicrobials used today were developed and generally 
tested against planktonic microorganisms in the laboratory, disregarding the increased 
resistance against antimicrobials in microorganisms living in biofilms (Smith, 2005). It is 
therefore necessary to look for new approaches to combat biofilm infections. Controlling 
microbial biofilm formation by targeting microbial communication could be a novel 
alternative. Such an approach would not kill the microorganisms, nor exert a selective 
pressure on the microorganisms. This would in best-case scenario not lead to resistance 
development. Halogenated furanones provide an interesting potential.  
Furanones - a new approach 
The discovery that the alga Delisea pulchra, in contrast to other algae in the surroundings, 
remained free from colonising organisms, challenged researchers to find an explanation. 
Studies showed that the alga produced various structurally similar halogenated furanones as 
secondary metabolites (Kazlauskas et al., 1977; Pettus et al., 1977; de Nys et al., 1992; de 
Nys et al., 1993; de Nys et al., 1996; de Nys et al., 1998). The furanones were found to be 
encapsulated and delivered to the surface of the alga at concentrations deterring both 
prokaryote and eukaryote fouling organisms. The inhibitory effect was assumed to be 
mediated through interference with microbial communication (Dworjanyn et al., 1999; 
Kjelleberg and Steinberg, 2001). Crude extracts of furanones isolated from the alga were also 
shown to be effective against early colonising marine microorganisms by repressing 
swarming, and by partly repressing attachment and growth (Maximilien et al., 1998).  
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Furanones from Delisea pulchra were shown to specifically interfere with a well 
conserved gene regulatory system found in a wide range of Gram-negative microorganisms 
(Givskov et al., 1996; Kjelleberg et al., 1997; Manefield et al., 1999; Manefield et al., 2002). 
This gene regulatory system involves a small diffusible signal molecule, AHL, also known as 
AI-1, which accumulates in the environment and thereby up- or down regulates specific genes 
according to cell-density in the surrounding (Fuqua et al., 1996). Later it was found that 
natural bromated furanones isolated from the alga, as well as their synthetic derivatives, 
inhibit multi-cellular behaviour induced by AI-1 such as swarming (Givskov et al., 1996; 
Gram et al., 1996; Rasmussen et al., 2000), biofilm formation (Hentzer et al., 2002; Hentzer 
et al., 2003; Wu et al., 2004) expression of virulence factors (Hentzer et al., 2003), as well as 
affecting the synthesis of siderophores (Ren et al., 2005), without affecting growth. 
Natural furanones isolated from Delisea pulchra were also found to inhibit swarming 
and biofilm formation induced by the universal AI-2 signal molecule used by Gram negative 
microorganisms (Ren et al., 2001) without affecting growth. The furanones also repressed the 
expression of several AI-2 induced genes connected to chemotaxis, motility and flagella (Ren 
et al., 2004). Furanones have also been shown to decrease swarming and biofilm formation by 
Bacillus subtilis and virulence gene expression by Bacillus anthracis, but with an effect on 
growth (Ren et al., 2002; Jones et al., 2005). A later study showed that furanones induced 
genes closely connected to stress response in Bacillus subtilis, as well as fatty acid synthesis, 
ribose transport and metabolism amongst others, whereas general growth genes were not 
affected (Ren et al., 2004).  
Synthetic furanones similar to the natural furanones isolated from Delisea pulchra 
were shown to inhibit microbial communication mediated by AI-1 (Hentzer et al., 2002; 
Manefield et al., 2002; Wu et al., 2004). At the start of the present study, there were a few 
studies on the effect of furanones on AI-2 mediated microbial communication in Escherichia 
coli (Ren et al., 2001; Ren et al., 2004), but no studies on a possible furanone effect on Gram 
positive microorganisms. Since several Gram-positive microorganisms regulate biofilm 
formation via AI-2 communication (Schauder et al., 2001; Federle and Bassler, 2003; McNab 
et al., 2003; Merritt et al., 2003; Yoshida et al., 2005; Petersen et al., 2006; Rickard et al., 
2006), our hypothesis was that synthetic furanone would inhibit biofilm formation via AI-2 
communication interference in these microorganisms. We were thus challenged to synthesise 
furanones and to assess possible effects on AI-2 dependent biofilm formation, in several 
Gram-positive microorganisms. It was furthermore intriguing to consider furanones’ 
suitability regarding irritability and toxicity. 
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Aims of the thesis 
The major aim was to synthesise chemically distinct furanones and to assess their ability to 
interfere with biofilm formation, as well as their irritative and toxic effects. 
 
The specific aims were to: 
1. Find alternative ways to synthesise (Z)-5-(bromomethylene)furan-2(5H)-one 
(Paper I) as well as different 5-(bromomethylene)furan-(5H)-ones and 3-
(bromomethylene)isobenzofuran-1(3H)-ones (Paper III). 
2. Investigate the effect of furanones on S. anginosus, S. intermedius, S. mutans 
(Paper II), and S. epidermidis biofilm formation (Paper III, Paper IV). 
3. Elucidate the mechanisms of action of the furanones by investigating 
- the furanones antimicrobial activity (Paper II, Paper III, Paper IV). 
- the ability of the synthetic furanones to interfere with AI-2 
communication assessed as bioluminescence inhibition (Paper II, 
Paper III, Paper IV). 
- the furanones effect on biofilm formation by luxS mutants compared 
to their wild types (Paper II). 
- whether the effect could be reversed by (S)-4,5-dihydroxy-2,3-
pentanedione (DPD), the precursor of AI-2 (Paper IV). 
4. Assess possible irritative and genotoxic effects (Paper IV). 
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Summary of results 
Furanone synthesis  
A new, easy and highly productive way to synthesise (Z)-5-bromomethylene-2(5H)-furanone 
(F202), a furanone found in the alga Delisa pulchra, was established. (Z)-5-bromomethylene-
2(5H)-furanone (F202) was synthesized in four steps from the commercially available adduct 
between furan and a maleic anhydride. A reaction between the derivative of the two starting 
products and a phosphorane gave the ester (E)-tert-butyl 2-(5-oxofuran-2(5H)-ylidene)acetate. 
The ester was then treated with trifluoroacetic acid to form the acid (E)-2-(5- oxofuran-2(5H)-
ylidene)acetic acid. Finally the (Z)-5-(bromomethylene)furan-2(5H)-one was prepared by 
bromodecarboxylation of the acid. After synthesis, the furanone was dissolved and diluted in 
absolute ethanol to a final stock concentration of 60 mM and stored at -20o C until use (Paper 
I). 
To further investigate possible effects of furanones, 5-(bromomethylene)furan-2(5H)-
ones and 3-(bromomethylene)isobenzofuran-1(3H)-ones were synthesised and thereafter 
assessed for their ability to interfere with microbial communication. 
The furanones were synthesised in three or four steps from commercially available 
maleic anhydrides and phthalic anhydrides respectively. First, unsaturated esters were 
prepared in the Wittig reaction and then transformed to 5-(bromomethylene)furan-2(5H)-ones 
in three different methods; A, B or C. The methods A and B comprised three steps whereas C 
comprised two. In method A, the esters were cleaved by trifluoroacetic acid in 
dichloromethane and then brominated to form α,β-dibromo acid. Thereafter the acid was 
debromodecarboxylated with triethylamine in dimethylformamide. Method A and B were 
similar, except that in B, the two first steps were switched. Method A gave somewhat better 
yield than B, but had a much longer reaction time. In method C, the unsaturated esters were 
cleaved to acids and then bromodecarboxylated by using bis(2,4,6-
trimethylpyridine)bromine(I)hexafluorophosphate in dichloromethane. This reaction gave a 
low to moderate yield, but the reaction was rather stereo-specific. The 3-
(bromomethylene)isobenzofuran-1(3H)-ones were formed using phtalic anhydrides as starting 
material in the methods described (Paper III). The furanones will later on be referred to by the 
names given to them in the studies; F101, F201-208, and F301-302. 
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Effect of furanones on biofilm formation 
Having established the methods to synthesise furanones, the next aim was to assess their 
effect on biofilm formation. 
F202 was investigated for ability to interfere with biofilm formation by S. anginosus, S. 
intermedius, and S. mutans, as well as by the isogenic AI-2 defective mutants of S. anginosus 
and S. intermedius. Biofilms were allowed to form on polyethylene surfaces with or without 
exposure to F202, which was either added to the growth medium or physically adsorbed to the 
surfaces. 
F202 added to the growth medium at the concentrations 0.6 or 6.0 µM decreased 
biofilm formation in all three streptococci in a concentration dependent manner (Paper II). 
Furanone coated wells were prepared by dissolving F202 to 60 mM in ethanol, and 
adding one millilitre of the dissolved furanone to wells of a polystyrene microtitre plate. The 
ethanol was left to evaporate in room temperature, leaving the furanone physically adsorbed 
to the surface of the wells. When surface adsorbed, F202 decreased biofilm formation by the 
streptococci to a higher degree than when added to the medium. Biofilm formation by S. 
intermedius and S. mutans on F202 adsorbed surfaces showed a substantial reduction, up to 
76% compared to the control. This was confirmed by scanning electron microscopy (Paper II). 
In a further biofilm assay where S. epidermidis was the biofilm forming 
microorganism, F302 was compared to the original F202. Biofilm was allowed to form on 
furanone adsorbed surfaces. Both F202 and F302 decreased the biofilm mass effectively, 
F202 being the most effective (Paper III). 
Four different furanones F201-F202, F206 and F302, were further assessed for effect 
on S. epidermidis biofilm formation. This was done to identify the most promising furanones 
for the prevention of microbial biofilm infections. All four furanones tested gave significantly 
decreased biofilm mass. F202 however, decreased biofilm significantly more than the other 
three and was therefore included in further studies. F206, which contained 2 bromo 
substituents and therefore seemed structurally interesting, was also subjected to further studies 
(Paper IV). 
Mechanism of action of furanones 
The ability of the microorganisms to communicate via AI-2, and the possible interference 
with this communication by furanones, was assessed in a bioluminescence assay. In this assay, 
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induction of bioluminescence in the AI-2 reporter V. harveyi BB170, was used as a sensor of 
microbial communication via AI-2. 
AI-2 production in S. anginosus, S. intermedius, S. mutans, S. epidermidis, and V. 
harveyi BB152, was confirmed by exposing their culture supernatants to the AI-2 biosensor. 
All streptococci (Paper II) and S. epidermidis (Paper IV) induced bioluminescence.  
At the concentrations 0.6 and 6.0 µM, F206 decreased induction of bioluminescence 
by all streptococcal supernatants in a concentration dependent manner, with 6.0 µM almost 
completely inhibiting the AI-2 mediated induction of bioluminescence (Paper II). 
The synthesised 5-(bromomethylene)furan-2(5H)-ones and 3-(bromomethylene) 
isobenzofuran-1(3H)-ones were also tested for interference of communication at 6.0 µM, with 
F202 included for comparison. One of the new furanones, F206, decreased AI-2 mediated 
induction of bioluminescence to a higher extent than F202 (Paper III).  
Finally, 11 furanones (including the ones already tested in Paper II and Paper III) were 
tested in the same bioluminescence assay at 6.0 µM to find the most effective inhibitor of AI-
2 mediated induction of bioluminescence. Supernatants collected from V. harveyi BB152 
were exposed to the AI-2 biosensor V. harveyi BB170. Four of the furanones markedly 
decreased AI-2 mediated induction of bioluminescence (Paper IV).  
The F202 concentrations used had no effect on V. harveyi, S. anginosus, S. 
intermedius, or S. mutans planktonic growth (biofilm combined with planktonic cells), or total 
growth of S. anginosus, S. intermedius, or S. mutans (Paper II). 
The total growth was unaffected for all furanones used in the S. epidermidis biofilm 
assay (Paper III and Paper IV). 
Minimum inhibitory concentration (MIC) for two selected furanones, F202 and F206, 
was approximately 16 and 26 times higher, respectively, than the concentrations necessary to 
inhibit biofilm formation (Paper IV). 
When added to the growth medium, furanones had no effect on biofilm formation by 
the communication defective S. anginosus luxS mutant or the S. intermedius luxS mutant. The 
communication defective mutants were also allowed to form biofilm on furanone-coated 
surfaces. The biofilm formation by the S. anginosus luxS mutant was unaffected (p>0.05), 
while biofilm formed by the S. intermedius luxS mutant was slightly lower when formed on a 
furanone adsorbed surface (Paper II). 
To further investigate whether the effect was related to interference with microbial 
communication, the AI-2 precursor (S)-4,5-dihydroxy-2,3-pentanedione (DPD) was added 
together with the furanones F202 and F206. The effect of the furanones was completely 
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abolished at the concentration 0.5 nM DPD, whereas DPD concentrations above and below 
0.5 nM attenuated the effect (Paper IV). 
Irritability and genotoxic assessments 
F202 and F206 were tested for irritability in the HET-CAM assay. Both furanones were found 
to be harmless at the concentrations used to prevent biofilm formation. First at 6000 µM, the 
first signs of any irritative effect were seen. For F202, initial signs of coagulation were 
observed, and for F206 a small bleeding as well as initial signs of coagulation were observed 
(Paper IV). 
Finally, possible genotoxic effects of F202 and F206 on global gene expression were 
investigated in mice. There were no clinical signs of adverse effects and no significant 
alterations in gene expression in the mice after ingestion of furanone for 21 days (Paper IV). 
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General discussion  
Treatment of infections is today mainly based on antimicrobials. This may, however, in many 
cases not be adequate, since antimicrobials generally are developed and tested against 
planktonic microorganisms, disregarding the nature of microorganisms organised in a biofilm. 
The rapid spread of antimicrobial resistance seen today, is another challenge. 
 The discovery that microorganisms communicate with each other to coordinately 
regulate genes opens new possibilities to fight microbial infections. By targeting microbial 
communication systems, we may decrease biofilm formation and thereby prevent diseases 
caused by biofilms. It may thus be easier to subsequently treat infections with relevant 
antimicrobials as the targeted microorganisms will be in planktonic phase. 
During the work of this study, we have investigated whether furanones would be 
potential agents for preventing biofilm formation in Gram-positive microorganisms (Paper II, 
Paper III and Paper IV). 
Furanone synthesis  
To consider furanones as potential agents for preventing biofilm associated infections, there 
was a need to find easy and inexpensive ways to synthesise furanones. Most studies on 
furanone interference with microbial communication have been based on natural furanones, 
whereas only few are based on synthetic furanones (Hentzer et al., 2002; Manefield et al., 
2002; Ren et al., 2004; Ren et al., 2004; Wu et al., 2004). 
First, we tried to synthesise a natural furanone that earlier had been tested for 
interference with microbial communication in Pseudomonas aeruginosa (Wu et al., 2004).  
This compound was named F202 in the present study (see Fig. 1 for structure). We designed a 
new and general way to synthesise different compounds, including F202 (Paper I). The 
scheme was simpler, and with a higher yield than by previously published schemes (Manny et 
al., 1997). Sorg and co-workers however published a new scheme in 2005. This scheme gave 
similar yield, but was less general (Sorg et al., 2005). 
Since Delisea pulchra is known to synthesise furanones of various structures, it was 
further interesting to see whether we could increase the efficacy by altering the structure of 
our furanones. Based on the synthesis pathway for F202, we were able to synthesise ten more 
furanones (F101, F201, F203-F208, and F301-F302) with the original main structure but with 
different side chains. We also varied the position of the halogen (F205, F207 and F301), as 
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well as exchanged halogen (F201). We also included two bromines in one furanone (F206) 
(Paper III). (See Fig. 1 for structures.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Chemical structures of the furanones included in this study.  
 
Effect of furanones on biofilm formation 
The discovery that microorganisms prefer a biofilm mode of growth rather than a free floating 
life style, and that they regulate their behaviour through communication, has changed the way 
we look at microorganisms. So far, we are only in the early beginning of using this knowledge 
in the prevention and treatment of biofilm associated diseases. 
 In previous studies of furanone efficacy, the furanones have been added to the growth 
medium (Ren et al., 2001; Ren et al., 2004) or to already existing biofilms (Hentzer et al., 
2002; Hentzer et al., 2003; Wu et al., 2004). We started our study by adding the compound 
F202 to the growth medium to investigate a possible inhibitory effect on biofilm formation. 
Since biofilm related infections often are connected to implants, we investigated whether a 
furanone covered surface would prevent biofilm formation, to the same degree as when 
adding the furanone to the growth medium (Paper II). This has been done earlier with other 
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furanone compounds, both in vitro and in mouse models (Hume et al., 2004; Baveja et al., 
2004 a; Baveja et al., 2004 b). We used a simple coating procedure where the furanones were 
dissolved in ethanol, which was then let to evaporate, leaving furanone physically adsorbed to 
the surface. For all streptococcal strains tested, this showed to be more efficacious than when 
adding furanone to the growth medium. The adsorbed furanone also effectively decreased S. 
epidermidis biofilm formation (Paper III, Paper IV). It is possible that part of the adsorbed 
furanone may dissolve and leak into the growth medium. The maximum possible furanone 
concentration by complete dissolution is 60 µM and would be antimicrobial. No antimicrobial 
effect was seen, however, since total growth, including both biofilm and planktonic cells, was 
unaffected. With the present coating procedure we cannot control how evenly the surface is 
coated or whether the entire surface is actually covered. There is therefore a future need to 
monitor the stability and to develop stable furanone films with even distribution of the active 
molecules. 
The efficacy of the furanones differed between the different structures; F202 decreased 
biofilm formation more than the other furanones tested (Paper IV). This was the case for all 
microbial strains included. Difference in efficiency between different structures has also been 
seen in studies of E. coli biofilm formation (Han et al., 2008) as well as in Salmonella 
enterica  (Janssens et al., 2008). 
Han and co-workers concluded that the most important structural element of the 
furanone for biofilm inhibition in E. coli is the bromine atom in the Z-position of the furanone 
ring. This is in accordance with our observations for streptococcal species (data not 
published), as well as the results of the bioluminescence assay comparing interference by 
F301 and 302 (Paper III, Paper IV).  In Salmonella, the furanones lacking an alkyl chain were 
the most effective inhibitors of biofilm formation, but at the same time they also delayed 
planktonic growth at low concentrations (Janssens et al., 2008). We also found the furanones 
lacking an alkyl chain to be most effective in decreasing biofilm formation. However, we 
observed no effect on growth at the concentrations used in our biofilm assays. Furthermore, 
the MICs established for the furanones F202 and F206 were more than twice that found for 
Salmonella (Janssens et al., 2008). Janssens and co-workers results also indicate that the 
biofilm inhibitory effect of the furanone decreased as the length of the alkyl side chain 
increased. These indications of structure dependent efficacy underline the need for more 
detailed structural screening studies. So far it seems crucial that a halogen is included in the 
structure and the position might be important. The length of the alkyl side chains also seems 
to be relevant (Paper IV). 
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Mechanism of action of furanones 
For possible clinical use of furanones, it is crucial to understand the mechanisms of action. 
This was examined by the following approaches, 1) investigating a possible antimicrobial 
effect, 2) examining interference with microbial communication, specifically AI-2 
communication, 3) assessing the inhibitory effect of furanone on AI-2 communication 
defective mutants, and finally 4) supplementation of synthetic communication signal, DPD, 
for competition with furanone.  
Antimicrobial effect 
All furanone concentrations used in the bioluminescence and biofilm assays were well below 
concentrations that had any effect on microbial growth (Paper II, Paper III, Paper IV). Biofilm 
formation by E. coli (Ren et al., 2001) and Salmonella (Janssens et al., 2008) was also 
inhibited by furanones at concentrations without an effect on growth. For the two compounds, 
F202 and F206, that showed the most promising results in the biofilm assay, we determined 
MIC to be 1000 and 1600 µM respectively. For both compounds, the maximum concentration 
that the microorganisms could possibly be exposed to through dissolution of the surface 
adsorbed furanone was 60 µM, well below the established MICs (Paper IV). Although 60 µM 
would restrain growth in some microorganisms, in none of our biofilm assays was the total 
growth affected, indicating that not all furanone was dissolved during the time of the assay. 
By this same coating method, Baveja and co-workers found that between 10-100 % of 
furanone remained on the surface after 24 hours incubation, depending on the surface material 
(Baveja et al., 2004 a). The anti-biofilm effect found in the present study could therefore most 
probably not be ascribed to an antimicrobial effect. Since growth was unaffected, the 
furanones will most likely not exert any selective pressure that may lead to resistance 
development.  
Microbial communication 
The luxS gene seems to be important for communication in a wide variety of microorganisms, 
and homologues have been found in all species used in this study (Merritt et al., 2003; 
Yoshida et al., 2005; Petersen et al., 2006; Xu et al., 2006; Ahmed et al., 2008). Through the 
bioluminescence assay, we reconfirmed that AI-2 is produced by the streptococcal strains 
(Blehert et al., 2003; Merritt et al., 2003; Wen and Burne, 2004; Yoshida et al., 2005; 
Petersen et al., 2006) as well as S. epidermidis (Xu et al., 2006), indicating that these species 
communicate via AI-2 signalling (Paper II). 
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The synthesised furanones clearly decreased induction of bioluminescence in V. 
harveyi BB170. Since this could not be ascribed to an antimicrobial effect, we assume that the 
furanones were able to interfere with microbial communication (Paper II, Paper III, Paper IV). 
An indication of AI-2-specific interference was that the furanones decreased bioluminescence 
induced in V. harveyi BB170, sensing only AI-2. Our results thus support previous findings of 
furanones decreasing bioluminescence mediated by AI-2 (Ren et al., 2004). The 
bioluminescence assay is an indirect method of detecting AI-2 signal molecules. 
Bioluminescence results should therefore be interpreted with caution (Turovskiy and 
Chikindas, 2006). Thus the exact mechanism of the anti-biofilm effect of the furanones seen 
in the studied microorganisms remains to be elucidated. Recent studies indicate that the 
quorum sensing regulator of V. harveyi, LuxR, (Waters and Bassler, 2006; Tu and Bassler, 
2007), is altered by furanone, making it unable to bind to the promoter of quorum sensing 
regulated genes (Defoirdt et al., 2007). By searching the genome of S. epidermidis we found 
two open reading frames encoding putative response-regulators belonging to the LuxR family. 
The function of these reading fames are however presently unknown, as well as their possible 
involvement in AI-2 communication. 
Wild type vs. luxS mutant  
In the streptococcal biofilm assay, we compared biofilm formation by the wild types and their 
corresponding luxS mutants (Paper II). We confirmed that the mutants formed less biofilm 
than their wild type counterpart (Petersen et al., 2006). When adding furanone to the growth 
medium, biofilm formation by the communication deficient luxS mutants of both S. anginosus 
and S. intermedius remained unaffected. The wild types that were able to communicate via 
AI-2 produced less biofilm in presence of furanone, supporting the effect on AI-2 
communication (Paper II). This provided further circumstantial evidence of a furanone effect 
through communication interference.  
 When biofilm was grown on furanone adsorbed surfaces, the S. anginosus luxS mutant 
was still unaffected. Biofilm formation by the S. intermedius luxS mutant was decreased to 
some degree but less than by its wild type. Assuming that furanone affects biofilm formation 
through AI-2 communication interference, the decreased biofilm formation is difficult to 
explain. Biofilm formation involves several steps, however. The S. intermedius mutant could 
possibly escape the effect of furanone by alternative pathways, since streptococci may use 
several other pathways to regulate biofilm formation, including peptide communication 
systems (Petersen et al., 2004). 
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DPD 
Even though AI-2 communication is found in a vast number of species, the AI-2 molecule 
seems to be diverse in different species. Most likely, the molecules are derived from the same 
precursor, (S)-4,5- dihydroxy-2,3-pentanedione (DPD) (Miller et al., 2004). DPD is highly 
reactive and rearranges spontaneously into a range of similar structures, collectively called 
AI-2 (Vendeville et al., 2005; De Keersmaecker et al., 2006). The AI-2 structures of V. 
harveyi and Salmonella typhimurium have been identified (Fig. 2), whereas the AI-2 in 
staphylococci and streptococci are still unknown. 
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Figure 2: Chemical structures of A1-2 from V. harveyi (left) (Chen et al., 2002) and S. 
typhimurium (right) (Miller et al., 2004).  
 
DPD is commercially available and by addition of DPD the effects of the two 
furanones on biofilm formation were eliminated. This was a strong indication that the 
furanones affect biofilm formation through interference with AI-2 microbial communication. 
Consistent with DPD being a quorum sensing signal, we found that the concentration needed 
to abolish the inhibitory effect of furanone was very low. There was also a narrow range of 
concentrations where DPD abolished the effect of the furanones (Paper IV). This is in line 
with previous studies, where it has been observed that a narrow range of concentrations of 
DPD induced a quorum-sensing response (Rickard et al., 2006; Ahmed et al., 2008).  
Xu and co-workers reported in a previous study that the luxS mutant of S. epidermidis 
formed more biofilm than its wild type (Xu et al., 2006).  This result opposes a furanone 
effect through inhibition of AI-2 communication and is in contrast with our results, showing 
that DPD competes with furanone and restores the ability of S. epidermidis to form biofilm. 
These contradictory results are difficult to explain, but could be related to factors such as 
biofilm growth conditions, e.g. growth medium, culture well materials, and quantification 
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methods. More recently, the same authors showed that externally added AI-2 almost 
completely restored the gene expression pattern of the wild type in S. epidermidis luxS mutant. 
They also found that AI-2 regulated the expression of phenol-soluble modulins, which seem 
to have a function in biofilm development (Li et al., 2008). This would support our 
assumption that furanones interfere with AI-2 mediated communication in S. epidermidis as 
well, although the role of AI-2 in S. epidermidis biofilm formation is still unresolved. 
It was previously assumed that furanones functioned as competitive inhibitors of AI-2. 
The structures of the known AI-2 molecules carry some similarity to the furanone compounds 
used in our studies (Fig. 1, Fig. 2). The present view of the furanone effect in V. harveyi is, 
however, that the gene regulator LuxR is prevented from binding to its promoter sequence 
(Defoirdt et al., 2007). To elucidate how the furanones function on a molecular-genetic level 
in Gram-positive microorganisms, such as the strains used in this study, requires further 
research.  
Furanones irritability and genotoxicity 
The next goal, after having identified two furanones that effectively decreased biofilm 
formation without an antimicrobial effect (F202 and F206), was to further assess their 
suitability for future clinical use. There are several studies on the potential of furanones to 
decrease biofilm formation (Ren et al., 2001; Hentzer et al., 2002; Ren et al., 2002; Hume et 
al., 2004; Baveja et al., 2004 a; Baveja et al., 2004 b; Christensen et al., 2007; Janssens et al., 
2008; Kim et al., 2008). There are, however, only few studies on the suitability for clinical 
use. These concern eukaryotic cell viability and toxicity, (Hume et al., 2004; Rasch et al., 
2004; Baveja et al., 2004 a; Baveja et al., 2004 b), whereas reports on irritative or genotoxic 
effects seems to be lacking. To consider whether furanones would be of clinical use against 
biofilm related diseases, there is a need for more thorough studies on possible adverse effects. 
To get a first impression on the suitability for clinical use, we tested the two 
compounds F202 and F206 for a possible irritative effect (Paper IV). To predict any irritative 
effect on the sensitive tissue surrounding a medical device, we used the HET-CAM method. 
This method, where the blood vessels of the CAM are exposed to the chemical, is comparable 
to the accepted and commonly used Draize eye irritation test (Balls et al., 1995). A score was 
calculated, taking all reactions of the CAM into consideration. From this score, an irritative 
potential was assessed (Kalweit et al., 1990). The first signs of irritative effects were not 
observed until a concentration of 6000 µM was used. This concentration was more than 100 
times higher than that necessary to affect biofilm formation. 
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A first attempt to assess possible genotoxic effects of furanones was made by using a 
mouse model (Paper IV). Genotoxicity was assessed as toxic reactions in mice using a 
membrane array comprising genes associated with toxic responses, followed by a study of the 
effect of the furanones on global gene expression using microarrays. None of the genes 
associated with toxic responses were significantly altered in expression by the furanones at 
concentrations decreasing biofilm formation. This was taken as evidence of no toxic 
responses to ingestion of the furanones by mice after 3 or 21 days. There were furthermore no 
signs of significant alterations in the expression of the 30 000 genes of the mouse genome by 
the furanones. This indicates that furanones could be interesting alternatives or adjuncts to the 
antimicrobials commonly used today. There is, however, need for further studies on the 
toxicology, including long-term studies and studies on offspring, as well as studies of delivery 
routes and vehicles. 
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Concluding remarks 
This thesis addresses a novel approach in the prevention of microbial biofilm related 
infections through interference with microbial quorum sensing communication by synthetic 
furanones. The rationale rests on the knowledge of biofilm formation as a well-regulated 
process. To form complex biofilm communities, the microorganisms coordinate their 
behaviour through quorum sensing communication. The resilient nature of microbial biofilms 
accounts for their causative role in persistent implant infections. Traditional treatment of these 
infections are generally targeted against planktonic cells, and are therefore often less suitable 
for treating biofilm related infections. Synthetic furanones that target microbial 
communication, such as AI-2 mediated communication, may decrease biofilm formation and 
virulence, without exerting a selective pressure and without adverse effects. Interference with 
microbial communication thus may represent a novel and promising strategy to control 
microbial biofilm infections.  
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Synthesis of 5-(bromomethylene)furan-2(5H)-ones and
3-(bromomethylene)isobenzofuran-1(3H)-ones as inhibitors
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(E)- and (Z)-5-(Bromomethylene)furan-2(5H)-ones and (E)- and (Z)-3-
(bromomethylene)isobenzofuran-1(3H)-ones have been prepared starting from commercially
available maleic anhydrides and phthalic anhydrides, respectively. A debrominative
decarboxylation or a bromodecarboxylation reaction is a key step in the synthesis. The furanones
were investigated for their ability to interfere with microbial communication and bioﬁlm
formation by Staphylococcus epidermidis.
Introduction
Many microorganisms communicate via chemical signal
molecules such as autoinducer-1 (AI-1) and autoinducer-2
(AI-2) to control gene expression in response to population
density.1 This phenomenon, called quorum sensing (QS),
regulates various virulence factors, for instance proteolytic
activity, carbohydrate metabolism and bioﬁlm formation.2,3
Thus interference with QS, in principle, would reduce the
pathogenic potential of a bacterium. Since this occurs without
exerting a selective pressure on microbial viability, resistance
development is not likely.
Most microorganisms in nature prefer a bioﬁlm mode of
growth4 and bioﬁlm formation is regulated by QS in a number
of microorganisms.5,6 Staphylococcus epidermidis is a Gram-
positive bioﬁlm forming commensal bacterium on human skin
and mucous membranes, as well as a major nosocomial
pathogen associated with medical implant infections.7 The
virulence is related to S. epidermidis’s ability to form bioﬁlm
on implanted devices. There are presently few eﬀective means
to prevent medical implant infections,8 mainly due to in-
creased resistance of bioﬁlm microorganisms to both antimi-
crobials and the human immune system, being up to 10–1000
times more tolerant to antimicrobials than their planktonic
counterparts.9 Thus antimicrobial treatment of implant infec-
tions often fails, necessitating removal of the implanted device.
Control of bioﬁlm formation by for instance S. epidermidis
represents a novel, non-antimicrobial approach of implant
infection prevention. Thus identiﬁcation of compounds that
inhibit QS has become an area of intense research.2 The macro
algae Delisea pulchra is known to prevent microbial colonisa-
tion of its surface by producing brominated furanones.10 Such
furanones are thought to interfere with microbial communica-
tion, mainly in Gram-negative microorganisms.
The aim of this study was to synthesize 5-(bromomethyl-
ene)furan-2(5H)-ones (2 and 3, Scheme 1) and 3-(bromo-
methylene)isobenzofuran-1(3H)-ones (4 and 5, Scheme 2)
and to assess their ability to interfere with microbial commu-
nication and bioﬁlm formation by S. epidermidis.
5-(Bromomethylene)furan-2(5H)-ones have previously
been prepared from levulinic acid11 or its derivatives,12
propenoates13 and allenic esters.14 3-(Bromomethylene)
isobenzofuran-1(3H)-ones have been prepared from 3-alkyli-
dene isobenzofuran-1(3H)-ones15 and by dehydration of bro-
mo keto acids.16
5-(Alkylidene)furan-2(5H)-ones, without the bromo substi-
tuent in the alkylidene group, have been synthesized from
maleic anhydrides in a Wittig reaction using stabilized phos-
phorus ylides.17 We wanted to use this method in our synthesis
since a number of maleic and phthalic anhydrides are com-
mercially available. The necessity to use stabilized phosphorus
ylides in the Wittig reaction indicates a bromodecarboxylation
step of an a,b-unsaturated acid in order to prepare the 5-
bromomethylene substituent. A number of methods have been
used in the bromodecarboxylation of a,b-unsaturated acids
having a b-aryl substituent.18 Without such a substituent the
methods are much more limited.19
Results and discussion
Synthesis of furanones
The unsaturated esters 1 (Scheme 1) were prepared in good
yields from commercially available maleic anhydrides in the
Wittig reaction and the esters were transformed into the 5-
(bromomethylene)furan-2(5H)-ones (2 and 3) in three ways
(Method A, B and C, Table 1). Methods A and B have three
steps, while Method C has two. All methods are one-pot
procedures—with only solvent evaporation between the steps.
In Method A the tert-butyl ester of 1 is ﬁrst cleaved by TFA
in dichloromethane and then brominated before the resulting
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a,b-dibromo acid is debromodecarboxylated with triethyl-
amine in DMF. Method B is similar to Method A except that
the two ﬁrst steps are switched. The yields in Method A are
somewhat better than the yields in Method B, but the reaction
times in Method A are much longer than in Method B. The
bromination of the unsaturated acids takes 3–4 days
with a large excess of bromine, while the bromination of
the unsaturated esters is over in a couple of hours with
a slight excess of bromine. The product distribution of
the E- and Z-isomer of the 5-(bromomethylene)furan-2(5H)-
one (2 and 3) is almost the same in these two methods
(Table 1). The Z-isomer is always the major isomer except in
one case (R1 and R2 = Me). The identity of the E- and
Z-isomers were determined by NOE experiments and/or by 1H
NMR chemical shift of the methine proton and any ring
protons.20
In Method C the unsaturated esters are cleaved to the acids
and then bromodecarboxylated using bis(2,4,6-trimethyl-
pyridine)bromine(I) hexaﬂuorophosphate in dichloromethane.
The yield in this reaction is low to moderate, 10–58% over two
steps (Table 1). The reaction shows some degree of stereo-
speciﬁcity since treatment of the pure E-isomer of the corres-
ponding acid of 1 (R1 = R2 = Me) gives mainly the
E-isomer (E : Z ratio 71 : 29) of the bromodecarboxylated
product. The pure Z-isomer gives only the Z-isomer.
The product ratios in Table 1 are probably not equal to the
thermodynamic ratios of the products, since treatment of
either pure 2c or pure 3c with iodine in CDCl3 gives the same
mixture of 2c and 3c (29 : 71) which is signiﬁcantly diﬀerent
from the ratio in Table 1 (12 : 88)
Phthalic anhydrides can also be used as starting material in
the synthesis discussed above. Thus the 3-(bromomethylene)-
isobenzofuran-1(3H)-ones 4a and 5a (R = H, Scheme 2) were
formed as a 1 : 2 mixture in 53% yield while the nitro
compounds 4b and 5b (R = NO2, Scheme 2) were formed as
a 1 : 1 mixture in 27% yield. We could separate the E- and
Z-isomers 4a and 5a by ﬂash chromatography but not the
nitro compounds 4b and 5b.
Bromination of the unsaturated ester 1 (Method B, step 1)
or the corresponding unsaturated acid (Method A, step 2) is
completely regioselective: only the exocyclic carbon–carbon
double bond is brominated at room temperature even if an
excess of bromine is used.
Bromination of ordinary alkenes is stereospeciﬁc.22 The
bromination of the unsaturated ester 1 (R1 = R2 = Me) or
the corresponding unsaturated acid is, however, not stereo-
speciﬁc because the pure E-isomer and the pure Z-isomer of 1
give the same mixture of dibrominated ester or acid (Scheme 3).
The isomerization occurs only in the bromination step,
since no isomerization was observed when a pure dibromide
Scheme 1
Scheme 2
Table 1 Yields and product distribution in the synthesis of 2 and 3
R1 R2
E : Z Starting
material 1 Methoda Product Yieldb 2 Yieldb 3 Total yieldb
E : Z
Product 2 : 3
H H 100 : 0 A 2a/3ac — — 61 5 : 85
H H 100 : 0 B 2a/3ac 2 44 46 4 : 96
H H 100 : 0 C 2a/3ac 22 0 22 100 : 0
Me H 100 : 0 A 2b/3b 10 77 87 11 : 89
Me H 100 : 0 B 2b/3b 7 46 53 13 : 87
Me H 100 : 0 C 2b/3b 32 6 38 84 : 16
Ph H 100 : 0 A 2c/3c 7 53 60 12 : 88
Ph H 100 : 0 B 2c/3c 6 45 51 12 : 88
Ph H 100 : 0 C 2c/3c 54 4 58 93 : 7
Br H 100 : 0 A 2d/3d 6 50 56 11 : 89
Br H 100 : 0 B 2d/3d 1 48 49 2 : 98
Br H 100 : 0 C 2d/3d 6 4 10 60 : 40
Me Me 0 : 100 A 2e/3e 66 9 75 88 : 12
Me Me 0 : 100 B 2e/3e 52 14 66 79 : 21
Me Me 0 : 100 C 2e/3e — — — 0 : 100d
Me Me 100 : 0 C 2e/3e 34 14 48 71 : 29
a Method A: 1. TFA, CH2Cl2, rt, 2 h; 2. Br2, CDCl3, rt, 2–3 d; 3. N(Et)3, DMF, rt, 2 h; Method B: 1. Br2, CDCl3, rt, 2–3 h; 2. TFA, CH2Cl2, 2 h; 3.
N(Et)3, DMF, rt, 2 h; Method C: 1. TFA, CH2Cl2, rt, 2 h; 2. Br
+(coll)2PF6
, CH2Cl2, rt, 2 h.
b Isolated yield. c Ref. 21. d From the 1H NMR of
the crude product.
1568 | New J. Chem., 2008, 32, 1567–1535 This journal is c The Royal Society of Chemistry and the Centre National de la Recherche Scientiﬁque 2008
(6, R = t-Bu) was carried through to the end product. The
5-bromomethylenefuran-2(5H)-ones will, however, isomerize
if the compounds are kept in a polar solvent like CDCl3 for a
couple of weeks. This tendency to isomerize can be utilized in
a synthesis of the natural product bovolide23 (7, Scheme 4). A
mixture of 2e and 3e was isomerized to pure 3e with iodine in
CH2Cl2 and coupled with butylzinc chloride in THF at room
temperature in a Pd(0)-catalyzed reaction.
The brominated furanone 3d (Table 1) has proven to be a
valuable intermediate in the synthesis of another g-alkylidene
butenolide: lissoclinolide.24
Interference with microbial communication and bioﬁlm
formation
All synthesized furanones (2e, 3b–e, 4a, 5a) and the reference
F20221 (Fig. 1) at 6.0 mM reduced bioluminescence in V.
harveyi BB170 signiﬁcantly (P o 0.01 compared to control
without furanone), with 5a being slightly more eﬀective than
the F202 reference (Fig. 2).
V. harveyi BB170 lacks the receptor for AI-1 and thus
responds only to intermicrobial communication via the AI-2
QS molecule. We assume therefore that the tested furanones
interfered with AI-2 QS communication. This is in line with
previous data in both Gram-negative25 and Gram-positive
microorganisms.26 More recently, furanones were found to
structurally alter LuxR in V. harveyi thus preventing binding
to promoter sequences.27 Further studies are needed to verify
the mechanism of action against S. epidermidis.
The two most eﬀective bioluminescence reducers (5a and
F202) were subsequently tested for eﬀect on bioﬁlm formation
by S. epidermidis. S. epidermidis carries the AI-2 synthase gene,
although its role in bioﬁlm formation is not clearly deﬁned. The
bioﬁlm assay clearly showed the bioﬁlm inhibitory potential of
both furanone 5a and F202 (P o 0.01 compared to control
without furanone). Furanone 5a reduced S. epidermidis bioﬁlm
by 57%, while the reference F202 reduced bioﬁlm formation by
68%. Notably, this reduction could not be ascribed to an
antimicrobial eﬀect since for both compounds, total growth
was unaﬀected (Fig. 3). These ﬁndings are interesting in view of
the increased use of implanted medical devices and the con-
comitant implant infections. We suggest that synthetic com-
pounds like 5a and F202, immobilised on implant surfaces, may
prevent implant infection. F202 was more eﬀective than 5a in
reducing bioﬁlm formation by S. epidermidis. F202 has pre-
viously been reported to interfere with colonization by the
Gram-negative Pseudomonas aeruginosa in lungs of experimen-
tally infected mice.28 Thus F202 appear to be able to interfere
with both AI-1 and AI-2 communication. The present and other
studies conﬁrm the possibility of interfering with microbial
virulence without inhibiting microbial growth.
Conclusion
We have shown that 5-(bromomethylene)furan-2(5H)-ones
and 3-(bromomethylene)isobenzofuran-1(3H)-ones can be
Scheme 3
Scheme 4
Fig. 1 Structure of compound F202, (Z)-5-(bromomethylene)furan-
2(5H)-one.21
Fig. 2 Bioluminescence response in the reporter strain V. harveyi BB
170 induced by V. harveyi BB152 supernatant and repressed by 6.0 mM
of furanones 2e, 3b–e, 4a, 5a or the reference F202. The results are
mean values and standard errors from three independent experiments
with three parallels. * Signiﬁcantly diﬀerent from control (ctr) without
furanone (P o 0.01).
Fig. 3 24 h Bioﬁlm formation by S. epidermidis on discs coated with
furanone 5a and the reference F202. The results are mean values and
standard errors from three independent experiments done in triplicate.*
Signiﬁcantly diﬀerent from control (ctr) without furanone (P o 0.01).
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easily synthesized in 3 or 4 steps from commercially available
maleic anhydrides and phthalic anhydrides, respectively. This
study also shows that furanones may be potential inhibitors of
microbial communication. The most eﬀective furanones, 5a
and F202, also reduced bioﬁlm formation by S. epidermidis
without aﬀecting the growth. The bioluminescence assay
indicates that the eﬃcacy may be structurally dependent. We
see a potential for furanones and isobenzofuranones in pre-
venting implant infections.
Experimental
The 1H NMR and the 13C NMR spectra were recorded on
Bruker Avance DPX instruments. Mass spectra, under elec-
tron impact conditions, were recorded at 70 eV ionizing energy
on a Fision ProSpec instrument.
Preparation of 5-(bromomethylene)furan-2(5H)-ones and 3-
(bromomethylene)isobenzofuran-2(3H)-ones
Method A. The a,b-unsaturated ester (1.0 mmol) was dis-
solved in a mixture of CH2Cl2 (1 mL) and TFA (1 mL). The
reaction mixture was stirred at room temperature for 2 h,
evaporated and redissolved in a mixture of CDCl3 (2 mL) and
TFA (0.1 mL). Bromine (2 mL, 2 M in CCl4) was added and
the mixture was stirred at room temperature until 1H NMR
showed that all starting material had been consumed (2–3 d).
The solvents were evaporated oﬀ and the residue was dissolved
in DMF (2 mL). Triethylamine (0.15 mL, 1.08 mmol) was
added at 0 1C and the mixture stirred at room temperature for
45 min before water was added. The product was extracted
into Et2O, washed with brine (3  10 mL), dried (MgSO4) and
evaporated. The E- and Z-isomers were separated by ﬂash
chromatography on silica gel.
Method B. Bromine (0.55 mL, 1.10 mmol, 2 M in CCl4) was
added to a solution of the a,b-unsaturated ester (1.0 mmol) in
CH2Cl2 (2 mL). The mixture was stirred at room temperature
for 2 h before the solvent was evaporated and the residue
dissolved in a mixture of CH2Cl2 (1 mL) and TFA (1 mL). The
mixture was stirred at room temperature for 2 h before the
solvent was evaporated oﬀ. The residue was dissolved in DMF
(2 mL) and triethylamine (0.15 mL, 1.08 mmol) was added at
0 1C. The mixture was stirred at room temperature for 45 min
before water was added and the product was extracted into
Et2O, washed with brine (3  10 mL), dried (MgSO4) and
evaporated. The E- and Z-isomers were separated by ﬂash
chromatography on silica gel.
Method C. The a,b-unsaturated ester (1.0 mmol) was dis-
solved in a mixture of CH2Cl2 (1 mL) and TFA (1 mL). The
reaction mixture was stirred at room temperature for 2 h,
evaporated and redissolved in CH2Cl2 (4 mL). Bis(2,4,6-
trimethylpyridine)bromine(I) hexaﬂuorophosphate29 (700 mg,
1.50 mmol) was added at 0 1C and the mixture was stirred at
0 1C for 15 min and at room temperature for 2 h before Et2O
was added. The Et2O was washed with 1M HCl, saturated
NaHCO3 and brine before it was dried (MgSO4) and evapo-
rated. The E- and Z-isomers were separated by ﬂash chroma-
tography on silica gel.
(E)-5-(Bromomethylene)-3-methylfuran-2(5H)-one (2b). Elu-
ent EtOAc–hexane 1 : 6 Rf 0.30; mp 52–56 1C; dH (300 MHz;
CDCl3) 2.01 (3H, Me), 6.33 (1H, s, CHBr), 7.37 (1H, m, H4);
dC (75 MHz; CDCl3) 11.03, 91.96, 133.42, 134.52, 150.93,
170.02; m/z (EI) 190 (M+ + 2, 63%), 188 (M+, 64), 125 (65),
122 (40), 120 (42), 97 (42), 68 (49), 39 (100); HRMS (EI) calcd.
for C6H5O2Br: 187.9472, found 187.9467.
(Z)-5-(Bromomethylene)-3-methylfuran-2(5H)-one (3b). Elu-
ent EtOAc–hexane 1 : 6 Rf 0.13; mp 91–94 1C; dH (200 MHz;
CDCl3) 1.95 (3H, Me), 5.91 (1H, s, CHBr), 7.03 (1H, m, H4);
dC (75 MHz; CDCl3) 10.75, 89.57, 131.24, 135.81, 151.18,
169.52; m/z (EI): 190 (M+ + 2, 99%), 188 (M+, 100), 162
(16), 160 (16), 122 (55), 120 (57), 53 (76); HRMS (EI) calcd. for
C6H5O2Br: 187.9472, found 187.9469.
(E)-5-(Bromomethylene)-3-phenylfuran-2(H)-one (2c). Elu-
ent EtOAc–hexane 1 : 3 Rf 0.48; dH (200 MHz; CDCl3) 6.48
(1H, s,QCHBr), 7.41–7.47 (3H, m, Ph), 7.82 (1H, s, H4),
7.91–7.96 (2H, m, Ph); dC (75 MHz; CDCl3) 93.89, 124.50,
128.78, 128.95, 130.43, 131.12 , 133.15, 150.75, 167.74; m/z
(M+) 252 (M+ + 2, 59%), 250 (M+, 60), 171 (100), 115 (74),
102 (88), 57 (20); HRMS (EI) calcd. for C11H7O2Br: 249.9629,
found 249.9626.
(Z)-5-(Bromomethylene)-3-phenylfuran-2(H)-one (3c). Elu-
ent EtOAc–hexane 1 : 3 Rf 0.32; mp 123–125 1C; dH
(200 MHz; CDCl3) 6.10 (1H, s,QCHBr), 7.40–7.44 (3H, m,
Ph), 7.47 (1H, s, H4), 7.85–7.90 (2H, m, Ph); dC (75 MHz;
CDCl3) 91.58, 127.15, 128.69, 128.91, 130.13, 131.30, 132.50,
151.03, 167.1; m/z (EI): 252 (M+ + 2, 68%), 250 (M+, 69),
172 (14), 171 (100), 116 (10), 115 (93), 102 (100), 76 (17);
HRMS (EI) calcd. for C11H7O2Br: 249.9629, found 249.9623.
(E)-3-Bromo-5-(bromomethylene)furan-2(5H)-one (2d). Elu-
ent EtOAc–hexane 1 : 6 Rf 0.23; mp 52–55 1C; dH (200 MHz;
CDCl3) 6.53 (1H, s,QCHBr), 7.83 (1H, s, H4); m/z (EI) 256
(M+ + 4, 49%), 254 (M+ + 2, 100), 252 (M+, 52), 228 (9),
226 (19), 224 (10), 175 (11), 173 (11), 149 (15), 147 15), 145
(15), 122 (18), 120 (19) 119 (17), 117 (17).
(Z)-3-Bromo-5-(bromomethylene)furan-2(5H)-one (3d).24 Eluent
EtOAc–hexane 1 : 6 Rf 0.15; mp 73–76 1C; dH (300 MHz; CDCl3)
6.19 (1H, s,QCHBr), 7.49 (1H, s, H4); dC (75 MHz; CDCl3)
93.27, 114.42, 139.42, 150.80, 164.01; m/z (EI) 256 (M+ + 4,
49%), 254 (M++2, 100), 252 (M+, 51), 228 (8), 226 (16), 224 (8),
145 (16), 147 (15), 53 (37). HRMS (EI) calcd. for C5H2O2Br2:
251.8421, found 251.8422.
(E)-5-(Bromomethylene)-3,4-dimethylfuran-2(5H)-one (2e). Elu-
ent EtOAc–hexane 1 : 4 Rf 0.40; mp 48–50 1C; dH (200 MHz,
CDCl3) 1.87 (3H, m, 4-Me), 2.35 (3H, m, 3-Me), 6.38 (1H, s,
QCHBr); dC (75 MHz, CDCl3) 8.8, 13.7, 91.3, 129.0, 146.2,
150.8, 169.0; m/z (EI) 204 (M+ + 2, 100%), 202 (M+, 100),
191(9), 189(9), 139(10), 127 (17), 122 (26), 120 (26); HRMS (M+)
calcd. for C7H7O2Br: 201.9629, found 201.9631.
(Z)-5-(Bromomethylene)-3,4-dimethylfuran-2(5H)-one (3e).
Eluent EtOAc–hexane 1 : 4 Rf 0.26; mp 113–116 1C; dH (200
MHz; CDCl3) 1.92 (3H, m, 4-Me), 2.10 (3H, m, 3-Me), 5.98
(1H, s,QCHBr); dC (75 MHz; CDCl3) 8.5, 9.6, 86.5, 125.7,
145.7, 152.7, 169.0; m/z (EI) 204 (M+ + 2, 100%), 202 (M+,
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100), 191(10), 189 (10), 176 (6), 174 (6), 122 (33), 120 (33), 111
(17), 67 (68); HRMS (M+) calcd. for C7H7O2Br 201.9629,
found 201.9634.
(E)-3-(Bromomethylene)isobenzofuran-1(3H)-one (4a). Elu-
ent EtOAc–hexane 1 : 6 Rf 0.23; mp 80–85 1C; dH (200 MHz;
CDCl3) 6.56 (1H, s,QCHBr), 7.62–8.46 (Ar); dC (75 MHz;
CDCl3) 91.05, 124.56,125.73, 125.97, 131.05, 134.70, 137.23,
147.49, 165.65; m/z (EI) 226 (M+ + 2, 98%), 224 (M+, 100),
170 (11), 168 (11), 104 (48), 89 (82), 76 (52); HRMS (M+)
calcd. for C9H5O2Br: 223.9472 found 223.9475.
(Z)-3-(Bromomethylene)isobenzofuran-1(3H)-one (5a).15 Elu-
ent EtOAc–hexane 1 : 6 Rf 0.15; mp 128–131 1C; dH (200
MHz; CDCl3) 6.33 (1H, s,QCHBr), 7.57–7.91 (Ar); dC (75
MHz; CDCl3) 85.72, 119.96, 124.47, 125.84, 130.56, 134.87,
137.90, 148.72, 165.54; m/z (EI) 226 (M+ + 2, 98%), 224
(M+, 100), 170 (10), 168 (10), 104 (36), 89 (83), 76 (41); HRMS
(EI) calcd. for C9H5O2Br: 223.9472, found 223.9476.
(E)- and (Z)-3-(Bromomethylene)-4-nitroisobenzofuran-1(3H)-
one (4b and 5b). Eluent EtOAc–hexane 2 : 3 Rf 0.35 gave a 1 : 1
mixture of 4b and 5b; dH (200 MHz; CDCl3) 6.95 (1H, s,
QCHBr), 7.59 (1H, s,QCHBr), 7.80–8.50 (2  3H, m, Ph);
m/z (EI): 271 (M++ 2, 23%), 269 (M+, 23), 218 (34), 190 (49),
161 (55), 104 (60), 75 (100), 57 (59).
(Z)-3,4-Dimethyl-5-pentylidenefuran-2(5H)-one (7).23 Zinc
chloride (3.0 mL, 1.5 mmol, 0.50 M in THF) was added
dropwise to a solution of n-butyllithium (0.15 mL, 1.5 mmol,
10 M) at 78 1C under N2. After 1 h a solution of (Z)-5-
(bromomethylene)-3,4-dimetylfuran-2(5H)-one (3e) (0.102 g,
0.5 mmol) in dry THF (5 mL) was added, followed by
tetrakis(triphenylphosphine)palladium [generated in situ from
tris(dibenzylideneacetone)dipalladium chloroform adduct
(0.026 g, 0.025 mmol) and triphenylphosphine (0.026 g,
0.1 mmol)] in dry THF (4 mL). The mixture was stirred at
room temperature for 18 h before the solvent was evaporated
oﬀ. The residue was dissolved in diethyl ether, washed with a
saturated solution of NH4Cl (10 mL) and brine. The solution
was dried (MgSO4), evaporated and the crude product puriﬁed
by ﬂash chromatography on silica gel. Eluent 0–15% EtOAc
in hexane; 0.61 g (68%) yellow oil; dH (200 MHz; CDCl3) 0.88
(3H, t, J = 7.0 Hz, –CH3), 1.30–1.42 (2  2H, m, 2  CH2),
1.86 (3H, s, 4-Me), 1.99 (3H, s, 3-Me), 2.32 (2H, q, J= 7.3 Hz,
CH2), 5 .17 (1H, t, J = 7.8 Hz, CHnBu); dC (75 MHz;
CDCl3) 8.48, 9.77, 13.74, 22.28, 25.60, 31.26, 110.86, 123.89,
146.83, 149.93, 170.93; m/z (EI): 180 (M+, 38%), 137 (98), 138
(16), 125 (27), 124 (100), 110 (16), 82 (17), 55 (65). HRMS (EI)
calcd. for C11H16O2: 180.1150, found 180.1147.
Interference with microbial communication
Bioluminescence assay. The bioﬁlm producing type strain
Staphylococcus epidermides ATCC35984, the AI-2 QS signal
producer Vibrio harveyi BB152, and the AI-2 QS signal
reporter Vibrio harveyi BB170 (the Vibrios were kind gifts
from Prof. B. L. Bassler) were included in the study. Growth
conditions for V. harveyi were as described previously.6,26,30
The second overnight culture of the reporter strain V. harveyi
BB170 was diluted 1 : 500 in fresh BA-medium and then stored
at70 1C until use.31 S. epidermidis was grown on Brain Heart
Infusion agar plates (BHI, Difco Laboratories, Detroit, MI,
USA) for 24 h at 37 1C in an aerobic atmosphere before
inoculation into Brain Heart Infusion medium (BHI, Difco
Laboratories, USA) for bioﬁlm formation and planktonic
growth.
A slightly modiﬁed bioluminescence assay was performed as
previously described6,26,30 to assess the ability of the various
furanones (2e, 3b–e, 4a, 5a) to interfere with QS communica-
tion. Furanone F202 was included as a reference. Brieﬂy, cell-
free supernatants prepared from V. harveyi BB152 were added
at ﬁnal concentration of 10% to BB170. The various fura-
nones were added to a ﬁnal concentration of 6.0 mmol L1
where upon bioluminescence induction was followed during
the next six hours in a Synergy HT Multi-Detection Micro-
plate Reader (Biotek, VT, USA).
Bioﬁlm assay. Bioﬁlm by S. epidermidis was allowed to form
during 24 h at 37 1C in an aerobic atmosphere on polystyrene
discs (Nunc) coated with furanone. Coating with furanone was
performed by adding 1 ml 60 mmol L1 furanone dissolved in
ethanol to each well. After 24 h, the solvent had evaporated.
Discs similarly treated but without furanone were included as
controls with no inhibitory eﬀect on bioﬁlm.
Bioﬁlm mass formed was quantiﬁed as follows; the discs
were rinsed twice in distilled water and stained for 10 min with
a 0.1% solution of safranin in new wells. The discs were rinsed
again, and bound safranin was released from stained cells
using 30% glacial acetic acid. OD measurements at 530 nm
were compared to the non-furanone coated control and the
reference F202.
To exclude an antimicrobial eﬀect of the furanones, total
growth, including both scraped bioﬁlm and planktonic cells,
was measured. After vigorous shaking to evenly disperse the
cells, total growth was quantiﬁed by measuring optical density
at 600 nm.
Statistics. Each assay was performed in triplicate in three
independent experiments. One-way ANOVA on Ranks fol-
lowed by Student–Newman–Keuls method for normal distri-
bution was used for multiple comparisons on bioﬁlm
formation and growth and for comparisons of biolumines-
cence induction. The level of signiﬁcance was set at Pr 0.01.
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